
Friwo manufactures power supply and charging solutions through development, manufacturing, and sales sites in Europe, Asia, and the US.
Medical and industrial volume contracts could raise Friwo's growth because long-term volume contracts in Medical & Healthcare Solutions convert into multi-year order intake and have raised order intake significantly. Order intake improved by 18% to 45.3 million euros, and the book-to-bill ratio of 1.3 confirms the demand shift. Stalling order intake without revenue growth would weaken that lift.
New customer projects need development, qualification and ramp-up before they add revenue, so the resulting revenue only gradually offsets declining demand. In February 2026, Friwo added the HERC250 model to its HERC open-frame series, offered in open-frame and caged versions.
FRIWO's recovery is a timing bet: order intake rose 18% to 45.3 million euros and the book-to-bill ratio reached 1.3, yet the revenue those orders represent materialises only after new customer projects clear development, qualification and ramp-up. That revenue will therefore only gradually offset declining demand, and the thesis breaks if the conversion slips again.
Group revenue fell to 42.3 million euros and EBIT was -3.1 million euros as at September 30, 2026. E-mobility and robotic lawn mowing face rising competition from Asian and other low-cost providers amid increasing price sensitivity, while the equity ratio stood at 31.8% and net debt at about 0.8 million euros on September 30, 2026.
Material scarcity and extended lead times in the supply chain could delay FRIWO's recovery because order delivery and revenue recognition for certain new-product launches are slipping to the 2027 financial year. A further guidance cut would confirm its backlog is not converting, beyond the Management Board's expectation of 2026 Group revenue of about 55 to 57 million euros and a negative adjusted EBIT of a low-to-mid single-digit million-euro amount.
Roughly 90% of the 804 employees recorded on September 30, 2026 are based at the Vietnamese locations. Long-term volume contracts in Medical & Healthcare Solutions raised order intake significantly. FRIWO's equity ratio stood at 31.8% on September 30, 2026, with net debt of about 0.8 million euros by the third quarter's end.